These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12619525)

  • 1. [Schizophrenia: adverse effects of atypical neuroleptics].
    Bettina Polk B
    Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing between atypical antipsychotics: weighing the risks and benefits.
    Bailey KP
    Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S2-S11. PubMed ID: 12046019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
    Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 6. Iloperidone: a clinical overview.
    Citrome L
    J Clin Psychiatry; 2011; 72 Suppl 1():19-23. PubMed ID: 22217439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
    McConville BJ; Sorter MT
    J Clin Psychiatry; 2004; 65 Suppl 6():20-9. PubMed ID: 15104523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms.
    Kerwin R
    BMJ; 2001 Apr; 322(7291):926-7; author reply 927-8. PubMed ID: 11302914
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
    Keltner NL
    Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroleptics and the extrapyramidal system].
    Haase HJ
    Arzneimittelforschung; 1978; 28(9):1536-7. PubMed ID: 38814
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important.
    Anderson I
    BMJ; 2001 Apr; 322(7291):926; author reply 927-8. PubMed ID: 11302919
    [No Abstract]   [Full Text] [Related]  

  • 14. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
    Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fewer adverse effects! Treatment with atypical neuroleptics].
    Müller N; Riedel M
    Pharm Unserer Zeit; 2002; 31(6):558-65. PubMed ID: 12481513
    [No Abstract]   [Full Text] [Related]  

  • 16. Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.
    Covell NH; Jackson CT; Weissman EM
    Postgrad Med; 2006 Sep; Spec No():20-6. PubMed ID: 17128658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unwanted effects of psychotrophic drugs. II.--Drugs for schizophrenia.
    Edwards JG
    Practitioner; 1977 May; 218(1307):696-700. PubMed ID: 18729
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotic and Bipolar Disorders: Antipsychotic Drugs.
    Holder SD; Edmunds AL; Morgan S
    FP Essent; 2017 Apr; 455():23-29. PubMed ID: 28437058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching in the era of atypical antipsychotics. An updated review.
    Weiden PJ
    Postgrad Med; 2006 Sep; Spec No():27-44. PubMed ID: 17128659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical antipsychotic-induced weight gain].
    Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.